Will the second Trump Administration manage AI’s risks—or ‘unshackle’ AI’s potential? 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

The U.S. Food and Drug Administration issued the recall notice for more than 200,000 pacemakers because a battery issue could lock the device in safe mode. 

Remote patient monitoring helps clinicians track heart patients as they recover from major operations. One surgeon described the technology as a "game-changer," highlighting the confidence patients feel when they have "an extra set of eyes on them."  

In patients with suspected stroke, contrast allergies present a significant dilemma, as contrast-enhanced imaging is often used to guide treatment decisions.

Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.

New expert recommendations from the American College of Cardiology were designed to help cardiologists, primary care physicians, emergency physicians, rheumatologists and other clinicians deliver the best care possible when managing suspected myocarditis. 

Last Christmas, Anna Jaques Hospital in Massachusetts suffered a ransomware attack. Now, nearly a year later, it confirms hackers stole personal information on 316,342 patients.